Myoblast transplantation and gene transfer in coronary artery disease - Adenoviral VEGF-C gene transfer and injected autologous myoblast cells in heart disease

by Pätilä, Tommi
State: New
$54.22
VAT included - FREE Shipping
Pätilä, Tommi Myoblast transplantation and gene transfer in coronary artery disease - Adenoviral VEGF-C gene transfer  and injected autologous myoblast cells in heart disease
Pätilä, Tommi - Myoblast transplantation and gene transfer in coronary artery disease - Adenoviral VEGF-C gene transfer  and injected autologous myoblast cells in heart disease

Do you like this product? Spread the word!

$54.22 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Tuesday, August 10, 2021 and Thursday, August 12, 2021
Sales & Shipping: Dodax

Check other buying options

1 Offer for $54.22

Sold by Dodax EU

$54.22 incl. VAT
State: New
Free Shipping
Delivery: between Tuesday, August 10, 2021 and Thursday, August 12, 2021
View other buying options

Description

Despite improved medical treatment and operative
possibilities,
end-stage coronary artery disease and heart failure
present a great
medical challenge.The progressive increase of elderly
population is
expected to further reflect in the incidences of
these disorders.
Recent progress in cell transplantation and gene
therapy has
provided a conceptual alternative for treatment of
heart failure and
coronary artery disease. In this report we review the
state of the art
intramyocardial myoblast cell treatment together
with gene therapy
of the heart.
We employed a porcine model and evaluated the
angiogenic effect
of vascular endothelial growth factor (VEGF)-C gene
transfer. During
the process, we concluded that the most used method
to produce
experimental ischemia shows significant inconsistency
and we
present our method of solving the problem. With our
new model, we
assessed the potential of autologous myoblast cell
transplantation
after ischaemia and infarction of the heart.

Contributors

Author:
Pätilä, Tommi

Further information

Biography Artist:
Tommi Pätilä is a Cardiothoracic Surgeon working in Helsinki
University Meilahti
Hospital. He is one of the founding members of Cell Therapy
Research Consortium
(CTRC), dedicated to research of novel treatment methods in
cardiac diseases.
Language:
English
Number of Pages:
116
Media Type:
Softcover
Publisher:
VDM Verlag Dr. Müller

Master Data

Product Type:
Paperback book
Package Dimensions:
0.22 x 0.15 x 0.007 m; 0.19 kg
GTIN:
09783639146318
DUIN:
QSNIJE783B2
$54.22
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.